What is the recommended technique for using a 1 mL 1:1000 (0.1 %) adrenaline (epinephrine) soaked gauze to control anterior epistaxis in adults, including contraindications and next steps if bleeding persists?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adrenaline-Soaked Gauze for Epistaxis Management

Adrenaline (epinephrine) 1:1000 soaked gauze is not the first-line treatment for anterior epistaxis and should only be considered after initial manual compression fails, with oxymetazoline spray being the preferred topical vasoconstrictor when pharmacologic intervention is needed. 1

Initial Management: Manual Compression First

  • The patient should sit upright with head tilted slightly forward (not backward) and apply firm, continuous pressure to the lower third (soft portion) of the nose for 10-15 minutes without releasing pressure to allow clot formation 2, 1
  • Breathing should occur through the mouth while spitting out blood rather than swallowing it 2, 1
  • Nasal pressure alone controls bleeding in approximately 80% of cases, making it sufficient as initial therapy in the vast majority of presentations 1

When Topical Vasoconstrictors Are Indicated

If bleeding persists after 15 minutes of continuous manual pressure, topical vasoconstrictors should be considered 1:

Preferred Agent: Oxymetazoline

  • Oxymetazoline nasal spray is superior to epinephrine-lidocaine combinations for achieving rapid hemostasis and reducing recurrence rates 3
  • In a 2025 prospective study, oxymetazoline achieved hemostasis in 71% of patients who failed pressure therapy, compared to only 49% with epinephrine-lidocaine (p=0.007) 3
  • Application technique: Clear clots by having patient blow nose, spray 2 sprays into bleeding nostril, then continue holding soft part of nose for 5 minutes; may repeat once 4

Epinephrine-Soaked Gauze: Secondary Option

  • A 2022 randomized controlled trial found no significant difference in bleeding stop times between topical lidocaine, epinephrine, and tranexamic acid (p=0.870 for lidocaine vs. epinephrine) 5
  • When epinephrine is used, the typical concentration is 1:10,000 dilution (not 1:1000) for topical nasal application to minimize systemic absorption and cardiovascular effects 6
  • The 1:1000 concentration mentioned in the question is too concentrated for routine topical nasal use and carries increased risk of systemic effects including hypertension and tachycardia 5

Technique for Topical Vasoconstrictor Application

When using any topical vasoconstrictor on gauze or packing 1, 6:

  1. Apply local anesthetic first if cautery will follow
  2. Soak gauze or packing material with the vasoconstrictor solution
  3. Place directly at the bleeding site for 8-10 minutes
  4. Limit application to the active bleeding site only to minimize tissue injury 1
  5. Monitor blood pressure, as epinephrine can cause significant hypertension 5

Contraindications and Precautions

Relative Contraindications to Epinephrine

  • Uncontrolled hypertension: Epinephrine caused statistically significant increases in both systolic and diastolic blood pressure compared to other agents 5
  • Severe coronary artery disease or recent myocardial infarction (systemic absorption risk)
  • Patients on MAO inhibitors or tricyclic antidepressants (drug interactions)

Special Populations

  • Patients on anticoagulants/antiplatelets: Use resorbable packing materials and attempt local hemostatic measures before considering anticoagulation reversal 1
  • Patients with bleeding disorders: Resorbable packing is preferred over non-resorbable materials 1

Next Steps If Bleeding Persists

Escalation Algorithm 1:

  1. If bleeding continues despite topical vasoconstrictors: Apply nasal cautery with silver nitrate to the identified bleeding site only 1, 7

    • Silver nitrate cauterization has an 80% success rate for anterior epistaxis 7
  2. If bleeding source cannot be identified: Place nasal packing (resorbable preferred in anticoagulated patients) 1

    • Merocel wrapped with Surgicel has shown effectiveness for diffuse bleeding 8
  3. If bleeding persists despite packing and cautery: Perform nasal endoscopy to locate the bleeding source 1

  4. Refractory cases: Consider surgical arterial ligation (endoscopic sphenopalatine artery ligation) or endovascular embolization 1

When to Seek Emergency Care

Immediate medical attention is required if 2, 1:

  • Bleeding does not stop after 15 minutes of continuous manual pressure
  • Patient becomes lightheaded from blood loss
  • Epistaxis is associated with trauma showing signs of brain injury, nasal deformity, or facial fracture
  • Patient is on anticoagulants/antiplatelets and bleeding has not completely ceased

Critical Pitfalls to Avoid

  • Do not tilt head backward: This directs blood toward the airway and stomach 1
  • Do not use 1:1000 epinephrine concentration topically: Use 1:10,000 dilution if epinephrine is chosen 6
  • Do not apply broad cauterization: Limit to the active bleeding site only to prevent tissue damage 1
  • Do not immediately discontinue anticoagulation: Attempt local hemostatic measures first unless bleeding is life-threatening 1
  • Cryotherapy (ice) lacks evidence: Not supported as a primary treatment modality 2, 1

Documentation Requirements

  • Document intervention outcomes within 30 days for patients treated with non-resorbable packing, surgery, or arterial ligation/embolization, or document transition of care 4, 1
  • Record type of packing used, expected removal schedule, and patient education provided 1

References

Guideline

Evidence‑Based Management of Epistaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

clinical practice guideline: nosebleed (epistaxis).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Research

An outcomes analysis of anterior epistaxis management in the emergency department.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.